These findings suggest that the LKB1/AMPK/mTOR signaling pathway possesses pivotal role in suppressing the progression of NAFLD, particularly in facilitating lipid breakdown and augmenting energy metabolism. The gene discussed is STK11; the disease is metabolic dysfunction-associated steatotic liver disease.